Following confirmation of the reduction in RAD21 mRNA levels in the RAD21-KD cells (Supplementary Fig. 1), CCK-8 assays were performed to determine the effect of RAD21-KD on the proliferative abilities of the NSCLC cell lines. This evidence concerns the gene RAD21 and non-small cell lung carcinoma.